Relapsing Babesiosis With Molecular Evidence of Resistance to Certain Antimicrobials Commonly Used to Treat Babesia microti Infections
Open Forum Infectious Diseases · 01.08.2023 · 10 (8)
DOI: 10.1093/ofid/ofad391 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Open Forum Infectious Diseases, online erschienen am 20.07.2023. Verfasst von Luis A Marcos und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases, Department of Medicine, Stony Brook University, Stony Brook, New York, USA. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Human babesiosis cases are emerging with an increased incidence and a wider geographic range worldwide. Relapsing babesiosis cases are becoming more frequently encountered in clinical practice associated with the use of immunosuppressive medications. The 2020 Infectious Diseases Society of America babesiosis guideline recommends at least 6 weeks of antimicrobial treatment for highly immunocompromised patients with Babesia microti infection. Nevertheless, cases have relapsed even after 6 weeks of treatment. Genetic mutations regarded as the potential cause of antimicrobial resistance in B microti have been identified in certain relapsing cases. A few alternative antimicrobial regimens have been used successfully to achieve cure for some of these cases, but other cases have had fatal outcomes. In this review, we discuss the molecular evidence of genetic resistance to certain antimicrobials commonly used to treat B microti infections based on an evaluation of 9 patients with relapsing infection.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Infectious Diseases, Department of Medicine, Stony Brook University, Stony Brook, New York, USA.
- Department of Microbiology and Immunology, Stony Brook University, Stony Brook, New York, USA.
- Division of Infectious Diseases, New York Medical College, Valhalla, New York, USA.
ORCID-Profile: Luis A Marcos
Zitieren
APA
Marcos, L. A., & Wormser, G. P. (2023). Relapsing Babesiosis With Molecular Evidence of Resistance to Certain Antimicrobials Commonly Used to Treat Babesia microti Infections. Open Forum Infectious Diseases, 10(8). https://doi.org/10.1093/ofid/ofad391
Vancouver
Marcos LA, Wormser GP. Relapsing Babesiosis With Molecular Evidence of Resistance to Certain Antimicrobials Commonly Used to Treat Babesia microti Infections. Open Forum Infectious Diseases. 2023;10(8). doi:10.1093/ofid/ofad391
BibTeX
@article{Marcos2023,
author = {Marcos, Luis A and Wormser, Gary P},
title = {Relapsing Babesiosis With Molecular Evidence of Resistance to Certain Antimicrobials Commonly Used to Treat Babesia microti Infections},
journal = {Open Forum Infectious Diseases},
year = {2023},
volume = {10},
number = {8},
doi = {10.1093/ofid/ofad391}
}
EUVIMED